April 30, 2024

Jan Willem Cohen Tervaert, MD, PhD, to Receive Lifetime Contribution to Autoimmunity Award

Jan Willem Cohen Tervaert, MD, PhD, will be honored with the Lifetime Contribution to Autoimmunity Award at the International Congress on Autoimmunity in May 2024.

Conexiant

June 19, 2025

GLP-1 Use Associated with Less Pain, Fatigue

At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.

Conexiant

December 05, 2024

MRI Shows Diet-Muscle Connection in Study

MRI study reveals direct correlation between ultra-processed food consumption and increased intramuscular fat infiltration, independent of calories or exercise, in adults without osteoarthritis.

Conexiant

April 29, 2024

Novel Therapies May Represent the Future of Treating Cutaneous Autoimmune Diseases

Excitement is growing around emerging novel therapeutics for patients with dermatomyositis and cutaneous lupus erythematosus, as Dr. Anthony Fernandez predicts the start of an exciting decade in the history of these two diseases.

Conexiant

June 06, 2025

New Global Criteria Define Pediatric Bone Disease

An international team developed and validated the first global classification criteria for pediatric chronic nonbacterial osteomyelitis, offering a standardized tool to improve research and diagnosis.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

June 16, 2025

Can Gout Therapy Protect Hearts Too?

New research shows achieving serum urate targets within1 year may significantly reduce major cardiovascular events in gout patients.

Conexiant

October 14, 2024

p300 KAT Inhibitors Offer Potential Approach for Inflammatory and Autoimmune Conditions

The preclinical abstract will be presented at ACR Convergence 2024 in November.

Conexiant

June 18, 2024

New EULAR Recommendations on CV Risk Management

EULAR has released new guidelines for managing cardiovascular risk in rheumatic and musculoskeletal diseases, focusing on regular screening, managing traditional and disease-related risk factors, and patient education.

Conexiant